HIV Infections: all 4,340 studies

Page 39 of 44. Open to participants first (240), then studies with results posted, then the rest; newest registration first within each.

• A Study of 1592U89 Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV DrugsCompletedNCT00002364Phase 2
• The Safety and Effectiveness of SPC3 in HIV-1 Infected PatientsCompletedNCT00002363Phase 1
• A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV DrugsSuspendedNCT00002362Phase 3
• Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease InhibitorsCompletedNCT00002361Phase 2
• A Study Comparing Two Forms of Didanosine in HIV-infected PatientsCompletedNCT00002360Phase 1
• A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL RegaCompletedNCT00002359Phase 3
• The Safety and Effectiveness of HBY 097 Used With or Without AZT in HIV-Infected Patients Who Have Mild or No SymptomsCompletedNCT00002357Phase 2
• A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive PatientsCompletedNCT00002354Not applicable
• A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human SubjectsCompletedNCT00002353Phase 1
• A Study of L-735,524 in HIV-Positive Children and AdolescentsCompletedNCT00002351Phase 1
• A Phase I Trial of APL 400-003 Vaccine: Safety and Immune Response Evaluations of Multiple Injections at Escalating Doses in Asymptomatic HIV-Infected PatientsCompletedNCT00002350Phase 1
• A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.CompletedNCT00002349Not applicable
• The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV InfectionCompletedNCT00002347Phase 2
• The Safety and Effectiveness of Bis-POM PMEA in HIV-Infected PatientsCompletedNCT00002346Phase 1
• A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMXCompletedNCT00002340Phase 3
• The Safety and Effectiveness of 935U83 in HIV-Infected PatientsCompletedNCT00002338Phase 1
• A Study of Multiple Doses of Vesnarinone in Advanced HIV DiseaseCompletedNCT00002337Phase 1
• The Safety and Effectiveness of 524W91CompletedNCT00002335Phase 1
• A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous TreatmentCompletedNCT00002334Phase 3
• A Study of Saquinavir and Zalcitabine, Used Alone and Together, in the Treatment of Advanced HIV Infection in Patients Who Stopped Taking or Who Cannot Take ZidovudineCompletedNCT00002333Phase 2
• A Study of Timunox (Thymopentin) in HIV-Infected Patients Receiving Other Anti-HIV DrugsCompletedNCT00002332Phase 2
• A Study of MDL 28,574A in HIV-Infected PatientsCompletedNCT00002329Phase 1
• The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected PatientsCompletedNCT00002327Phase 1
• The Safety and Effectiveness of Zidovudine Plus Adefovir in HIV-Infected PatientsCompletedNCT00002326Phase 1
• The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the DiseaseCompletedNCT00002324Phase 2
• A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ CellCompletedNCT00002323Not applicable
• A Study of Different Doses of Atevirdine Mesylate Plus Zidovudine in HIV-Positive PatientsCompletedNCT00002322Phase 2
• A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the PastCompletedNCT00002320Phase 3
• The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal MeningitisCompletedNCT00002316Phase 1
• A Study of Nystatin in HIV-Infected PatientsCompletedNCT00002313Phase 1
• The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take ZidovudineCompletedNCT00002312Not applicable
• The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive PatientsCompletedNCT00002311Phase 1
• A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV DrugsCompletedNCT00002308Not applicable
• A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected PatientsCompletedNCT00002307Not applicable
• The Safety and Effectiveness of Ribavirin in the Early Stages of HIV-InfectionTerminatedNCT00002298Not applicable
• The Safety and Effectiveness of Zidovudine Plus Acyclovir in Patients With Early HIV InfectionCompletedNCT00002290Not applicable
• The Effects of Thymopentin on HIV Infectivity of Blood Cells and Semen in HIV-Infected PatientsCompletedNCT00002289Not applicable
• The Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous SystemCompletedNCT00002288Not applicable
• A Study of Retrovir in the Prevention of HIV Infection in Health Care Workers Accidentally Exposed to the VirusCompletedNCT00002287Not applicable
• A Study of Azidothymidine (AZT) in the Treatment of HIV Infection in Patients Receiving a Bone Marrow TransplantCompletedNCT00002284Not applicable
• An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other ImmunodeficienciesCompletedNCT00002272Not applicable
• An Ascending, Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected SubjectsCompletedNCT00002271Not applicable
• A Multicenter, Double-Blind, Controlled Study to Evaluate AmpligenCompletedNCT00002269Not applicable
• A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or ViruriaCompletedNCT00002268Phase 1
• An Open Parallel Study to Determine the Optimum Dosing Schedule for AS-101 in AIDS/ARC PatientsCompletedNCT00002266Not applicable
• An Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of Dideoxycytidine (ddC) in Patients With AIDS or Advanced ARC Who Previously Demonstrated Intolerance to Zidovudine (AZT) in Protocol N3300 or N3492CompletedNCT00002265Phase 2
• An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected SubjectsCompletedNCT00002260Not applicable
• Dideoxycytidine ( Ro 24-2027 ). A Treatment Protocol for the Use of Dideoxycytidine ( ddC ) in Patients With AIDS or Advanced ARC Who Cannot Be Maintained on Zidovudine ( AZT ) Therapy.CompletedNCT00002256Not applicable
• An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC)CompletedNCT00002255Phase 1
• A Multi-Center, Open-Label, Ascending, Multiple Oral Dose, Safety, Tolerance and Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC)CompletedNCT00002254Not applicable
• A Double-Blind Study to Evaluate the Safety and Pharmacokinetics of L-Ofloxacin (RWJ 25213) in Subjects With HIV InfectionCompletedNCT00002249Phase 1
• A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected PatientsCompletedNCT00002245Phase 3
• A Study to Evaluate the Safety and Effectiveness of WF10 Given to Patients With Late-Stage HIV DiseaseCompletedNCT00002244Phase 3
• A Study to Evaluate the Safety and Effectiveness of a New Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), (+)-Calanolide A, in HIV-Positive Patients Who Have Never Received Anti-HIV TreatmentCompletedNCT00002243Phase 1
• Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice DailyStatus unknownNCT00002241Phase 2
• Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV DrugsCompletedNCT00002240Phase 2
• A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected AdultsCompletedNCT00002239Phase 2
• Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT RegimenCompletedNCT00002238Phase 3
• A Study of Peldesine (BCX-34) in HIV-Infected PatientsCompletedNCT00002237Phase 1
• A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive PatientsCompletedNCT00002236Not applicable
• A Study of a Combination of Four Drugs in Patients With Recent HIV InfectionCompletedNCT00002233Phase 2
• A Study of GENEVAX-HIV, a Possible VaccineCompletedNCT00002232Phase 1
• Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative VolunteersCompletedNCT00002231Phase 1
• A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected PatientsCompletedNCT00002230Phase 3
• Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected PatientsCompletedNCT00002229Phase 4
• A Study of T-20 in HIV-Positive AdultsCompletedNCT00002228Phase 2
• A Study of Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV DrugsCompletedNCT00002227Phase 2
• A Study of Efavirenz in Combination With Stavudine and DidanosineCompletedNCT00002225Phase 2
• Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)CompletedNCT00002224Phase 3
• A Study of Ritonavir/Indinavir Combination in HIV-Infected PatientsCompletedNCT00002223Not applicable
• Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With NelfinavirCompletedNCT00002220Phase 3
• Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected ChildrenStatus unknownNCT00002219Phase 2
• A Phase I Maximum Tolerated Dose Study of CI-1012 in Late-Stage HIV+ PatientsCompletedNCT00002218Phase 1
• A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV DrugsCompletedNCT00002217Not applicable
• A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV TreatmentCompletedNCT00002216Not applicable
• A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-NaiveCompletedNCT00002215Not applicable
• Phase I Trial of S-1153 in Patients With HIV InfectionCompletedNCT00002214Phase 1
• The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease InhibitorsCompletedNCT00002213Phase 2
• Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected PatientsCompletedNCT00002211Not applicable
• A Study of Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and BabiesCompletedNCT00002210Phase 2
• A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TCCompletedNCT00002208Phase 3
• A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected PatientsCompletedNCT00002207Not applicable
• A Study of Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Been Treated With Anti-HIV DrugsCompletedNCT00002206Phase 1
• A Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy HIV-Seronegative AdultsCompletedNCT00002204Phase 1
• A Study of Two Anti-HIV Drug CombinationsCompletedNCT00002203Not applicable
• A Comparison of 141W94 and Indinavir in HIV-Infected PatientsCompletedNCT00002202Phase 3
• A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected PatientsCompletedNCT00002201Not applicable
• A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.CompletedNCT00002199Phase 3
• A Study of 1592U89 and Ethanol When Given Together to HIV-Infected PatientsCompletedNCT00002198Phase 1
• A Study of 1592U89 in HIV-Infected ChildrenCompletedNCT00002197Not applicable
• A Study of CI-1012 in HIV-Infected PatientsCompletedNCT00002196Phase 1
• A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected PatientsCompletedNCT00002195Phase 3
• An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4.CompletedNCT00002194Phase 1
• Safety and Effectiveness of Giving Two Nucleoside Reverse Transcriptase Inhibitors Alone or in Combination With 141W94 to HIV-Infected Children Who Have Never Received Protease InhibitorsCompletedNCT00002193Phase 3
• A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected PatientsCompletedNCT00002190Phase 2
• Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)CompletedNCT00002186Not applicable
• A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected PatientCompletedNCT00002184Phase 2
• A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV InfectionCompletedNCT00002183Phase 1
• A Study of Megestrol Acetate in HIV-Infected ChildrenCompletedNCT00002182Not applicable
• A Study of PMPA in HIV-Infected PatientsCompletedNCT00002180Phase 1

← HIV Infections overview